Imunon Inc.

NASDAQ: IMNN · Real-Time Price · USD
6.42
-0.18 (-2.73%)
At close: Aug 15, 2025, 3:59 PM
6.71
4.52%
Pre-market: Aug 18, 2025, 08:16 AM EDT

Imunon Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
727.16K 727.16K 727.16K n/a n/a n/a n/a 125K 250K 375K 500K 500K 500K 500K 500K 500K 500K 500K
Cost of Revenue
915.43K 750.76K 552.83K 189.25K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-188.27K -23.6K 174.33K -189.25K n/a n/a n/a 125K 250K 375K 500K 500K 500K 500K 500K 500K 500K 500K
Operating Income
-16.02M -18.27M -19.13M -20.95M -19.9M -20.36M -21.03M -21.99M -24.26M -24.76M -24.92M -23.49M -22.37M -21.47M -21.01M -20.31M -19.41M -19.1M
Interest Income
275.06K 337.64K 450.22K 361.26K 509.56K 734.52K 935.28K 1.2M 1.1M 844.29K 502.58K 248.07K 90.69K 30.18K 18.14K 10.66K 7.23K 23.89K
Pretax Income
-15.75M -17.79M -18.62M -20.73M -19.36M -20.13M -20.8M -29.43M -32.1M -32.58M -37.47M -28.27M -27.53M -26.94M -22.15M -21.41M -24.07M -23.96M
Net Income
-15.75M -17.79M -18.62M -19.45M -18.08M -18.85M -19.51M -27.86M -30.53M -31.02M -35.9M -26.89M -26.15M -25.55M -20.77M -19.56M -22.22M -22.12M
Selling & General & Admin
6.94M 7.76M 7.49M 7.99M 8.25M 8.4M 9.74M 11.38M 13.34M 13.88M 13.69M 12.27M 11.1M 10.82M 10.89M 10.37M 9.44M 8.74M
Research & Development
8.92M 10.51M 11.64M 12.96M 11.65M 11.96M 11.29M 10.74M 11.17M 11.26M 11.73M 11.72M 11.78M 11.14M 10.62M 10.44M 10.47M 10.86M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
15.86M 18.27M 19.13M 20.95M 19.9M 20.36M 21.03M 22.11M 24.51M 25.14M 25.42M 23.99M 22.87M 21.97M 21.51M 20.81M 19.91M 19.6M
Interest Expense
n/a n/a n/a n/a n/a 37.09K 197.08K 347.39K 474.42K 542.35K 5.03M 4.97M 4.94M 5.06M 569.88K 636K 991.21K 1.11M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
16.02M 18.27M 19.13M 20.95M 19.9M 20.36M 21.03M 22.11M 24.51M 25.14M 25.42M 23.99M 22.87M 21.97M 21.51M 20.81M 19.91M 19.6M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
1.47M 1.12M 1.11M 1.11M 720.73K 720.65K 720.65K 718.89K 700.47K 634.91K 570.11K 544.24K 535.28K 442.4K 29.49K 442.41K 439.17K 338.86K
Shares Outstanding (Diluted)
1.47M 1.12M 1.11M 1.11M 720.73K 720.65K 720.65K 718.89K 700.47K 634.91K 570.11K 544.24K 535.28K 442.4K 29.49K 442.41K 439.17K 338.86K
EPS (Basic)
-13.57 -18.34 -21.51 -24.64 -25.1 -26.4 -28.36 -44.79 -51.25 -54.6 -69.47 -189.39 -190.32 -191.44 -184.55 -55.91 -89.97 -112.54
EPS (Diluted)
-13.57 -18.34 -21.51 -24.64 -25.1 -26.4 -28.36 -44.79 -51.25 -54.6 -69.47 -189.39 -190.32 -191.44 -184.55 -55.91 -89.97 -112.54
EBITDA
-15.07M -17.1M -17.98M -20.12M -18.74M -19.47M -19.88M -28.28M -30.85M -31.29M -31.71M -22.62M -21.93M -21.19M -20.88M -20.06M -22.33M -22.11M
EBIT
-15.79M -17.84M -18.7M -20.81M -19.44M -20.18M -20.6M -29.08M -31.62M -32.04M -32.44M -23.3M -22.59M -21.88M -21.58M -20.77M -23.08M -22.85M
Depreciation & Amortization
717.14K 737.73K 718.12K 693.39K 702.43K 705.64K 720K 797.53K 770.83K 750.32K 731.63K 673.73K 661.07K 686.31K 702.92K 712.2K 746.34K 743.79K